Adding neurotensin to lung cancer cells increases phosphatidylinositol turnover, resulting in elevating cytosolic Ca2+ and activating protein kinase C. SR48692 is an NTSR1 antagonist, which inhibits lung cancer proliferation. Here, NTSR1 is linked to lung carcinoma.